Iza-bren improved survival and delayed disease progression versus chemotherapy in previously treated metastatic ...
New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the ...
12don MSN
Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows
A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer ...
A new antibody‑drug conjugate nearly doubles survival and extends overall survival in advanced triple‑negative breast cancer, ...
Metastatic progression reduction is associated with GLP-1 RA initiation after cancer diagnosis across multiple solid tumors.
A novel PET imaging approach enables simultaneous visualization of tumor progression and cardiac inflammatory responses during cancer treatment.
Clinical trials at Emory and Piedmont are signaling a potential breakthrough in treating pancreatic cancer, one of the nation ...
The FDA has approved capivasertib (Truqap) in combination with abiraterone acetate (Zytiga) and prednisone for adults with ...
Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results